JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

RELEASE DATE
07-Mar-2013

REGION
North America

Research Code: 9561-00-F3-00-00

SKU: LS00245-NA-MR_17659

~~USD 1,500.00~~

USD 1,125.00 save 25 %

*Links

downloadable link

* Required Fields

~~USD 1,500.00~~

USD 1,125.00 save 25 %

ENQUIRE NOW

Description
Table of Contents
Request Sample

Description

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies.

Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.

Table of Contents

Vital Signs: 7 March 2013

This week's issue

Related Research

The Most Lucrative Market for CROs in the Asia Pacific in 2015

Top Technologies in Health and Wellness--2013 (Technical Insights)

2013 Europe; New Product Innovation - Extremolyte Therapeutics for Allergies

Frost & Sullivan Awards for Impact of Biomarkers (Technical Insights)

Frost & Sullivan Awards for Innovations in Allergy Diagnostics and Treatment--Technical Insights

Vital Signs - Healthcare News - The Analysts Perspective - February Issue

Vital Signs - The Healthcare News - March Issue

Vital Signs - The Healthcare News - April Issue

Vital Signs - Healthcare News - The Analysts Perspective June Issue

Vital Signs - Pointing Towards Point-of-Care Testing - The Next Big Shift

Popular Topics

heavy truck market

neurology devices market

composite materials market

glucose monitoring devices market

automotive aftermarket

video analytics market

smart wearables market

augmented reality market

polypropylene market

plastic recycling market